30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Singhal Priya

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 75% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Singhal Priya's trades of Biogen Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-10 2026-02-09
US Biogen Inc (BIIB)
S Sale
27,486 -45.2%
53.15
US$1,858,513 		27,486 -45.2% 53.15 US$1,858,513
2026-02-09 2026-02-09
US Biogen Inc (BIIB)
PrS Proposed sale
30,414
182.82
US$3,951,409 		30,414 182.82 US$3,951,409
2026-02-03 2026-02-02
US Biogen Inc (BIIB)
S Sale
77,110 +7.0%
187.97
US$2,417,230 		77,110 +7.0% 187.97 US$2,417,230
2026-02-03 2026-02-02
US Biogen Inc (BIIB)
S Sale
748 -10.7%
179.30
US$134,116 		748 -10.7% 179.30 US$134,116
2026-02-02 2026-02-02
US Biogen Inc (BIIB)
PrS Proposed sale
748
179.30
US$134,116 		748 179.30 US$134,116
2025-09-02 2025-09-02
US Biogen Inc (BIIB)
PrS Proposed sale
517
133.55
US$69,045 		517 133.55 US$69,045
2025-09-02 2025-09-02
US Biogen Inc (BIIB)
S Sale
517 -8.2%
133.55
US$69,045 		517 -8.2% 133.55 US$69,045
2025-05-20 2025-05-19
US Biogen Inc (BIIB)
PlS Planned sale
3,806 -41.2%
126.25
US$480,508 		3,806 -41.2% 126.25 US$480,508
2025-05-19 2025-05-19
US Biogen Inc (BIIB)
PrS Proposed sale
3,806
126.25
US$480,508 		3,806 126.25 US$480,508
2024-12-09 2024-12-09
US Biogen Inc (BIIB)
PrS Proposed sale
110
157.21
US$17,293 		110 157.21 US$17,293
2024-12-09 2024-12-09
US Biogen Inc (BIIB)
S Sale
110 -2.0%
157.21
US$17,293 		110 -2.0% 157.21 US$17,293
2024-09-05 2024-09-03
US Biogen Inc (BIIB)
S Sale
431 -7.5%
204.22
US$88,019 		431 -7.5% 204.22 US$88,019
2024-09-03 2024-09-03
US Biogen Inc (BIIB)
PrS Proposed sale
431
204.22
US$88,019 		431 204.22 US$88,019
2024-04-03 2024-04-02
US Biogen Inc (BIIB)
PlS Planned sale
93 -1.9%
213.09
US$19,817 		93 -1.9% 213.09 US$19,817
2024-04-02 2024-04-02
US Biogen Inc (BIIB)
PrS Proposed sale
93
213.09
US$19,817 		93 213.09 US$19,817
2024-02-26 2024-02-22
US Biogen Inc (BIIB)
S Sale
262 -5.1%
221.23
US$57,962 		262 -5.1% 221.23 US$57,962
2024-02-22 2024-02-22
US Biogen Inc (BIIB)
PrS Proposed sale
262
221.23
US$57,962 		262 221.23 US$57,962
2024-02-21 2024-02-21
US Biogen Inc (BIIB)
PrS Proposed sale
108
221.49
US$23,921 		108 221.49 US$23,921
2024-02-21 2024-02-16
US Biogen Inc (BIIB)
S Sale
108 -2.1%
221.49
US$23,921 		108 -2.1% 221.49 US$23,921
2024-02-13 2024-02-12
US Biogen Inc (BIIB)
S Sale
419 -8.5%
239.45
US$100,330 		419 -8.5% 239.45 US$100,330
2024-02-12 2024-02-12
US Biogen Inc (BIIB)
PrS Proposed sale
419
239.45
US$100,330 		419 239.45 US$100,330
2024-02-05 2024-02-02
US Biogen Inc (BIIB)
S Sale
634 -13.4%
245.93
US$155,920 		634 -13.4% 245.93 US$155,920
2024-02-02 2024-02-02
US Biogen Inc (BIIB)
PrS Proposed sale
634
245.93
US$155,920 		634 245.93 US$155,920
2023-12-12 2023-12-11
US Biogen Inc (BIIB)
S Sale
110 -3.1%
248.00
US$27,280 		110 -3.1% 248.00 US$27,280
2023-12-11 2023-12-11
US Biogen Inc (BIIB)
PrS Proposed sale
110
248.00
US$27,280 		110 248.00 US$27,280
2023-09-06 2023-09-05
US Biogen Inc (BIIB)
S Sale
431 -11.4%
269.43
US$116,124 		431 -11.4% 269.43 US$116,124
2023-09-05 2023-09-05
US Biogen Inc (BIIB)
PrS Proposed sale
431
269.43
US$116,124 		431 269.43 US$116,124
2023-07-05 2023-07-03
US Biogen Inc (BIIB)
S Sale
81 -2.7%
282.87
US$22,912 		81 -2.7% 282.87 US$22,912
2023-07-03 2023-07-03
US Biogen Inc (BIIB)
PrS Proposed sale
81
282.87
US$22,912 		81 282.87 US$22,912
2023-04-06 2023-04-04
US Biogen Inc (BIIB)
PlS Planned sale
91 -3.1%
277.11
US$25,217 		91 -3.1% 277.11 US$25,217
2023-04-04 2023-04-04
US Biogen Inc (BIIB)
PrS Proposed sale
91
277.11
US$25,217 		91 277.11 US$25,217
2023-03-30 2023-03-28
US Biogen Inc (BIIB)
PlS Planned sale
568 -16.7%
270.06
US$153,394 		568 -16.7% 270.06 US$153,394
2023-03-28 2023-03-28
US Biogen Inc (BIIB)
PrS Proposed sale
568
270.06
US$153,394 		568 270.06 US$153,394